vorinostat has been researched along with Liver Diseases in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Liver Diseases: Pathological processes of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Deng, M | 1 |
| Wu, H | 1 |
| Wang, M | 1 |
| Gong, J | 1 |
| Bai, H | 1 |
| Wu, Y | 1 |
| Pan, J | 1 |
| Chen, Y | 1 |
| Li, S | 1 |
1 other study available for vorinostat and Liver Diseases
| Article | Year |
|---|---|
Suberoylanilide hydroxamic acid alleviates orthotopic liver transplantation‑induced hepatic ischemia‑reperfusion injury by regulating the AKT/GSK3β/NF‑κB and AKT/mTOR pathways in rat Kupffer cells.
Topics: Animals; Autophagy; Glycogen Synthase Kinase 3 beta; Kupffer Cells; Liver; Liver Diseases; Liver Tra | 2020 |